In Alzheimer's disease cholinergic neurons degenerate, resulting in loss of hippocampal acetylcholine. The fimbria-fornix aspiration is a well-known animal model mimicking hippocampal cholinergic deficiency. The aim of the present study was to use in vivo lipid-mediated gene transfer to introduce an expression vector coding for the acetylcholine synthesizing enzyme choline acetyltransferase into the hippocampus to replace the loss of enzyme activity after unilateral fimbria-fornix aspiration. Our data show that the lipid FuGene is useful to transfer DNA in vitro into 3T3 fibroblasts, C6 glioma cells, and primary astroglia and to express the respective enzyme. Lipid-mediated gene transfer in vivo resulted in a marked but transient expression of green fluorescent protein below the injection site peaking 5 days after the injection. Unilateral fimbria-fornix aspiration led to a marked reduction in the activity of choline acetyltransferase in the hippocampus, which was completely replaced 5 days after lipid-mediated gene transfer of the choline acetyltransferase vector. In conclusion, our data provide evidence that lipid-mediated gene transfer using FuGene is a useful tool to replace loss of choline acetyltranseferase activity in the hippocampus after fimbria-fornix aspiration; however, the lack of good gene transfer efficiency and the transient nature of expression limit its use for clinical applications.
INTRODUCTION
shown to result in significant reduction of hippocampal acetylcholine levels. There has been extensive interest in the possibility to Alzheimer's disease is characterized by a marked degeneration of cholinergic neurons in the basal forebrain repair the fimbria-fornix pathway and to restore cholinergic activity in the hippocampus (40, 45) . Two experi-(septum and nucleus basalis of Meynert) with subsequent massive reductions of acetylcholine in circumscribed re-mental approaches have been shown to be very efficient in rescuing hippocampal cholinergic activity: either gions of the neocortex, hippocampus, and amygdala (1, 8, 12, 29, 30, 36, 38, 41, 44, 47) . Preclinical research interest transplantation of genetically modified cells secreting neuroprotective growth factors (e.g., nerve growth fac-has focused on the septohippocampal system (4,10) to produce a deficit in forebrain cholinergic activity. Al-tor) (33, 37) or transplantation of genetically modified cells synthesizing and secreting acetylcholine (9,46). though animal models for Alzheimer's disease are not available, two animal models are extensively used to in-Recent progress in molecular neurobiology shows that direct gene transfer methods may be of importance to duce deficits in cholinergic innervation in the hippocampus: lesion of cell bodies in the septum (e.g., with exci-counteract neurodegenerative disorders by causing expression of neuroprotective or neuroregenerative factors totoxins or by electrolytical lesions or using a selective immunotoxin) or axotomy of the nerve fiber bundles in the brain. Especially viral gene transfer has been shown to be highly efficient to protect neurons (e.g., that connect the cholinergic septal neurons with the hippocampus (fimbria-fornix pathway). A lesion of the lat-dopaminergic) against cell death (6, 24) . However, concerns about safety in using viruses call for the develop-ter type can be performed mechanically by aspiration (9, 22, 39) or using a stereotaxic knife. The fimbria-fornix ment of alternative strategies. Such an alternative is lipid-mediated transfection (lipofection), which is a sim-lesion is a well-established animal model and has been 682 WEIS, KAUFMANN, AND HUMPEL ple technique to introduce DNA into mammalian cells at 37°C. The cells were washed twice in prewarmed Op-timemI, and then the lipid-DNA mix was carefully (11, 17, 26) . Cationic lipids interact spontaneously and rapidly with polyanions such as DNA (11). The resulting (drop by drop) added to the cells. The cells were incubated with the lipid-DNA complex at 37°C/5% CO 2 for polycationic lipid-DNA complexes fuse with the anionic surface of cells, delivering DNA into the cells pos-8 h (single transfection) or for 6 h on 3 consecutive days (boost transfection), then the solution was aspirated, and sibly via endocytosis. Recently, the novel lipid FuGene has been introduced and we described for the first time full medium was applied. Cells were incubated at 37°C/ 5% CO 2 in an incubator for 5 (single transfection) or 3 the characteristics of this lipid to transfer DNA into malignant cells (42, 43) and primary astroglia (42, 43) , mi-(boost transfection) days. croglia (unpublished), and neurons (42) . The aim of this Immunohistochemistry for ChAT project is to observe if lipid-mediated in vivo gene trans-Immunohistochemistry using the avidin-biotin techfer of an expression vector coding for choline acetylnique was performed as previously described (42, 43) . transferase (ChAT) may restore enzyme activity in the Cells were fixed for 10 min at 4°C with 4% paraformalhippocampus after unilateral fimbria-fornix aspiration.
dehyde, washed three times in 50 mM Tris-buffered sa-MATERIAL AND METHODS line (TBS) for 10 min at room temperature, blocked in Expression Vectors pEF−, pEF-GFP, and pEF-ChAT 1% H 2 O 2 /TBS containing 0.3% Triton X-100 and, after thorough rinsing, in 10% horse serum diluted in 0.1% For all experiments the expression vector pEF con-Triton X-100/TBS. Cells were incubated with primary taining the strong human elongation-factor-1α promotor ChAT (1:750, Chemicon) antibody in a humidity-satuwas used as described (23, 42, 43) . In this expression vecrated chamber at 4°C for 2 days. The cells were washed tor the genes coding for green fluorescent protein (pEFand incubated with secondary biotinylated anti-goat an-GFP) and for ChAT (pEF-ChAT) were subcloned. The tibody (1:200, Vector Lab.) for 1 h at room temperature. GFP gene (719 bp) was subcloned from the cloning vec-After washing, cells were incubated in ABC-Vectastain tor phGFP-S65T (Clonetech) into the pEF− vector via reagent for 30 min, washed in TBS, and then the signal the EcoRI site (blunt ended). The full-length coding rewas detected by using 0.05% 3,3′-diaminobenzidine gion (1.9 kb) of ChAT was subcloned from the vector (DAB) including 0.003% H 2 O 2 as a substrate. pcDNA3-ChAT [a kind gift of Prof. Carlos Ibanez (18)] into the pEF− vector via the EcoRV sites. The sequence
ChAT Assay corresponds to base pairs 194-2128 according to Brice
ChAT activity was assayed using the Fonnum protoet al. (2) . Endotoxin-free plasmid DNA was purified uscol modified by Pongrac and Rylett (32) . Briefly, 1 ml ing the Quiagen plasmid purification kit (Qiagen).
of extraction buffer (10 mM PBS, pH 7.4, containing 1 C6 Glioma Cells, 3T3 Fibroblasts, mM NaCl, 0.87 mM EDTA, 0.15 mM eserine salicylate, and Primary Astroglia and 0.5% Triton X-100) were added to the hippocampal tissue. After sonication the homogenates were diluted to C6 glioma cells and 3T3 mouse fibroblasts were cula final concentration of 3 mg wet weight/ml and extured at 37°C in 5% CO 2 in culture medium (10% fetal tracted on ice for 30 min. For in vitro measurements, calf serum, DMEM, without antibiotics/antimycotics) as cells were trypsinized 3 days after the last transfection described recently (42, 43) . Primary astroglia were culwith 50 µl 0.25% trypsine per 24-well for 2 min at 37°C, tured as described by Wiesenhofer et al. in our lab resuspended in serum-free medium, and centrifuged for (42, 43) . Briefly, the whole brain of newborn rats was 5 min at 1000 rpm. The pellets were stored at −80°C dissected, trypsinized, triturated, and the cells (1500 until the assay was performed. The cells were collected cells/mm 2 ) plated on poly-DL-ornithine-coated wells. in 25 µl extraction buffer, sonicated, and incubated on Cells were incubated in medium (5% horse serum, 0.5% ice for 30 min. To start the enzyme reaction 7 µl of fetal calf serum, in OptimemI) for up to 14 days.
incubation solution containing 1 µl of [ 3 H]acetyl-CoA Lipid-Mediated Gene Transfer In Vitro (250 nCi; Amersham, Austria) in incubation buffer (0.05% BSA, 0.1 mM eserine salicylate, and 2 mM cho-Lipid-mediated gene transfer was performed as described in detail recently (42, 43) . Briefly, C6 or 3T3 line chloride in PBS) were added to 7 µl of each homogenate. Duplicates of each probe were measured. After cells (10,000 cells/16-mm well) or primary astroglia cells were incubated in a 16-mm well (24-well) over-50 min at 37°C the reaction was stopped by adding 100 µl cold water, followed by organic-phase extraction of night in medium without antibiotics/antimycotics. To prepare the lipid-DNA complex, 1.7 µl FuGene (Roche, [ 3 H]acetylcholine with 300 µl of sodium-tetraphenylborate in 3-heptanone (20 mg/ml). Two hundred microliters Austria) was mixed with 255 ng DNA in OptimemI (for a single 24-well plate) and incubated at least for 15 min of the organic phase was added to 2 ml scintillation fluid and measured in a scintillation counter (Beckman). Sam-hippocampi dissected, and the ChAT activity measured. Unlesioned animals were used as a control. To observe ple protein content was determined by the method of Bradford (1) .
the intensity of the lesion, animals were only lesioned and their ChAT activity observed after 2 weeks. To Lipid-Mediated Gene Transfer In Vivo measure any effect of the injection of the lipid-DNA Using pEF-GFP mix the ChAT activity was measured 5 days after only To prepare the lipid-DNA mix, 3 µl FuGene was a single lipid-DNA injection into the hippocampus. mixed with 450 ng DNA (pEF-GFP) in a total volume Quantitative Measurements and Statistics of 10 µl OptimemI and allowed to react for at least 15
The intensity of green fluorescent cells was analyzed min at room temperature. Male Sprague-Dawley rats on a blind basis on coded sections by one investigator (250 g, Himberg, Austria) were narcotized with 50 mg using an image analysis system. Eight-bit gray scale imthiopental/kg (Sanabo). Animals were placed in a stereoages of brain sections were scanned using the Image Pro taxic frame, the skull was opened, and a hole was drilled software (Media Cybernetics, Silver Spring, MD, USA) at the respective stereotaxic coordinates. To perform with a CCD Video camera (Sony) system linked to a easy and reproducible injections, the lipid-DNA mix BX60F Olympus fluorescence microscope. The signal (10 µl) was injected into the middle of the striatum [cointensity was measured on a gray scale from 0 to 255 ordinates: bregma 0.2; lateral: −3.0; deep: −5.0; calcuarbitrary units (0 = black; 255 = white). From one brain lated according to the brain atlas of Paxinos and Watson section three areas of 0.15 mm 2 were analyzed and val-(31)] using a thin modified plastic pipette (Stratagene) ues were averaged. Cultured cells were counted under connected to a multipipette syringe. After insertion of the microscope at a 20× magnification using a 0.29 mm 2 the plastic pipette, the lipid-DNA mix was injected into grid. Positive cells were counted in 30 adjacent fields. the brain and the syringe was left for 3 min in the brain.
Values were averaged and the total number of positive After removal, the skin was closed and the animals alcells per area was calculated. Multistatistical analysis lowed to survive for 1, 2, 4, 5, 6, 8, 12, 14, or 21 days.
was obtained by one-way ANOVA with subsequent Animals were sacrificed and the brains were removed
Fisher PLSD post hoc test. and fresh frozen under a CO 2 stream. Brains were sectioned (20 µm), thawed on glass slides, posttreated with RESULTS ethanol 70%-90%-100% each for 2 min, and embedded Lipid-Mediated Gene Transfer In Vitro in Entellan. Brain sections were investigated under the fluorescence microscope (Olympus, Hamburg, Germany)
Cells transfected with the empty vector pEF− reusing a wide band WB filter (BP450-480).
vealed only background staining ( Fig. 1A) . Lipid-mediated gene transfer of the expression vector pEF-ChAT Fimbria-Fornix Lesion and Lipid-Mediated into 3T3 fibroblasts ( Fig. 1B ), C6 glioma cells (Fig. 1C ), Gene Transfer of pEF-ChAT or primary astroglia ( Fig. 1D ) revealed strong positive The fimbria-fornix lesion was performed by vacuum ChAT staining 5 days after the transfection (C6, 3T3) aspirations. Male Sprague-Dawley rats (220-250 g, Himor 3 days after boost transfection (primary astroglia). berg, Austria) were narcotized using 50 mg thiopental/ Quantitative analysis showed that a high number of kg. The animals were placed in a stereotaxic instrument.
fibroblasts, C6 glioma cells, and primary glial cells The skull was exposed and a hole was drilled (coordiexpressed ChAT (Fig. 1E ). Transfection with the connates: bregma: −1.4; lateral: −1.5). A Pasteur pipette trol vector (pEF−) revealed only background staining connected to a vacuum tube was slowly inserted into the ( Fig. 1E ). brain (coordinates: ventral −4.0). The lesion was per-Detection of ChAT in Transfected Cells formed on the right side and the contralateral side served and Hippocampus as a control. The skin was sutured and the animals allowed to recover. Nine days after the lesion the animals Testing different concentrations of recombinant ChAT (rChAT) (0-30 mU) showed an assay linearity were again narcotized (50 mg/kg thiopental) and placed in the stereotaxic frame. The skull was exposed and a up to 10 mU rChAT (data not shown). When determining the incubation time in the ChAT assay, a clear lin-second hole was drilled (coordinates: bregma: −2.8; lateral: −1.6). The lipid-DNA mix (10 µl) (pEF− or pEF-earity of the enzyme reaction was found up to 60 min of incubation (data not shown). Testing rat hippocampus ChAT) was injected into the hippocampus (ventral: −3.4) using the thin modified plastic pipette connected of normal adult untreated rats (0.2-205 µg) in the assay it was found that up to 20 µg tissue wet weight/assay to a multipipette syringe as described above. Animals were allowed to recover for 5 days. Then the animals produced linearity (data not shown). Addition of rChAT to the hippocampal tissue produced a clearly enhanced were decapitated, their brains removed, the right and left signal while addition of recombinant acetylcholine esterase decreased the acetylcholine produced by the same amount of rChAT (data not shown). Transfection of 3T3 fibroblasts, C6 glioma cells, and primary astroglia revealed ChAT activities of 283 ± 132 mU ChAT/mg protein (n = 3), 383 ± 60 mU ChAT/mg protein (n = 3), and 1293 ± 533 mU ChAT/mg protein (n = 3), respectively. It needs to be mentioned that the background levels in the ChAT assay in control (pEF−)-transfected 3T3 cells and less pronounced in C6 cells was markedly enhanced compared with primary astroglia, possibly reflecting unspecific turnover of 3-H-AcetylCoA in malignant cells.
Lipid-Mediated Gene Transfer of pEF-GFP In Vivo
Control transfection of C6 glioma cells with the vector pEF-GFP showed strongly fluorescent cells ( Fig.  2A ). Injection of vehicle (OptimemI) alone, or FuGene alone (3 and 10 µl OptimemI) or empty expression vector pEF− alone (450 ng DNA in 10 µl OptimemI; Fig.  2B ) resulted in a faint diffuse autofluorescence (4.7-5.1 arbitrary units) around the injection site, while no fluorescence was detectable on the contralateral side. Injection of 450 ng pEF-GFP complexed with 3 µl FuGene (in a total volume of 10 µl OptimemI) revealed a specific strong intensity of 32.5 ± 6.0 arbitrary units 5 days after injection. Several strongly fluorescent round-oval cells were visible below the injection site (Fig. 2C ). Analysis of GFP expression at different time points showed a clear transient expression peaking around 4-6 days after injection (Fig. 2D ), while no fluorescence was visible at the contralateral side.
Restoration of ChAT After Fimbria-Fornix Lesion by Lipid-Mediated Gene Transfer
Measurement of ChAT activity in the hippocampus of untreated control animals revealed an average of 467 ± 11 mU ChAT/mg protein. The left and right hippocampus did not differ in their activity (Table 1) . A fimbria-fornix lesion significantly reduced the ChAT ac- Table 1) . Injection of the lipid-DNA complex cells (C) or rat primary astroglia (D). As a control the vector using the empty expression vector (pEF−) did not affect pEF− was transfected into C6 glioma cells (A). Cells were ChAT activity ( Table 1) . Injection of the empty expresplated, 3T3 and C6 cells were transfected for 8 h with lipid-DNA, and cells were analyzed after 5 days by ChAT immuno-sion vector pEF− 9 days after a fimbria-fornix lesion histochemistry. Primary astroglia were boost transfected and had no influence upon the lesion effect (Table 1) . Howanalyzed after 3 days. The number of positive darkly stained ever, when the vector pEF-ChAT was injected into the cells was counted in 30 adjacent fields under the microscope hippocampus 9 days after a fimbria-fornix lesion, ChAT (E). Values are given as mean ± SEM. ChAT-positive cells per activity was raised again to control levels (Table 1) . lipid-mediated gene transfer of an expression vector coding for ChAT restored levels of ChAT activity in the hippocampus. However, the lack of good gene transfer efficiency limits the use of this method for clinical applications.
Lipid-mediated gene transfer has several advantages (27) . Most importantly, it is very simple, not dangerous, and less time consuming than other methods. It is also not associated with the risk of side effects, such as toxicity or immune response. A transient expression reduces the possibility that transfected cells undergo malignant transformation, forming brain tumors. And finally, several different genes can be delivered simultaneously. However, the usefulness of lipid-mediated DNA transfection is limited because of its low efficiency [see (7, 42, 43) ] (e.g., lipids may easily stick to different materials or may not easily diffuse through the brain environment). In fact, Felgner et al. (11) reported that lipid-DNA complexes are very sticky and can adhere to glassware but not to polystyrene. In our previous study we reported (43) that the application of lipid-DNA to glass dramatically reduced the gene transfer efficiency in vitro. Thus, we decided not to use glass microsyringes, but we used specially modified plastic syringes with a very narrow long tip.
Normally, lipids display a high cellular toxicity when applied at too high concentrations. Our previous data showed that the correct lipid-DNA concentration is very critical for an efficient nontoxic delivery (43). While Imaoka et al. (19-21) used an enormous amount of lipid (90 µg) and DNA (30 µg), our previous studies (42, 43) clearly showed that a concentration of 450 ng DNA per application at a constant ratio of 150 ng DNA per 1 µl FuGene was very successful. Because the in vivo gene transfer is limited in injection volume, we decided to inject a complex of 450 ng DNA and 3 µl FuGene in 10 µl OptimemI. It also needs to be considered that the lipid stock is delivered in an 80% ethanol solution, thus 2.4 µl ethanol was injected. Although our data do not provide evidence of toxicity, it cannot be excluded that the present approach may induce microglial infiltration, astrogliosis, or neuronal loss. pEF-GFP (450 ng DNA + 3 µl FuGene and 10 µl OptimemI) into the middle of the striatum and detection 5 days after the transfection. Note several fluorescence-stained round-oval The expression vector GFP has been used as a control Unilateral aspirative lesions of the fimbria-fornix pathway produce significant deficits in ChAT activity in to observe in vivo gene transfer. Our data clearly show that lipid-mediated gene transfer of GFP in vivo was the hippocampus. The histological changes that occur following an unilateral lesion are well documented successful and that cells could be transfected with this method in a time-dependent pattern, with a maximum (9,16). Aspiration of the fimbria-fornix leads to a marked decrease in ChAT activity in the hippocampus. after 5 days. Thus, this time point was used for assaying ChAT activity after injection of the lipid-DNA complex However, the axotomy did not result in complete loss of hippocampal ChAT activity. This can be explained by into the fimbria-fornix-lesioned animals. Our results also show that the lipid-mediated gene transfer is limited to several reasons. First, the existence of cholinergic interneurons in the hippocampus has been reported (14). a relatively restricted area below the injection site, which is also in line with Imaoka et al. (19, 20) . Physical While these interneurons do not sprout in response to removal of the cholinergic input (13), sprouting of axons damage, like an injection into the brain, causes reactive gliosis and activation of microglia at the injection site. from the contralateral side seems to be likely. Alternatively, it may be possible that the aspiration was not This activation is very rapid and peaks 5-7 days after the lesion. Thus, the proliferative activity of glial cells complete and that surviving axons sprouted and increased their ChAT activity. Indeed, Lapchak et al. (25) is markedly elevated after injection of the lipid-DNA complex. Imaoka et al. (20) confirmed by double label-described that residual cholinergic neurons are able to sprout after partial lesion, thus compensating for lesion-ing analysis that most of the cells transfected by lipidmediated gene transfer were a population of reactive induced loss of cholinergic neurons. Neurodegeneration of dopaminergic or cholinergic astrocytes. Although we did not perform colocalization experiments, our studies may indicate that the cells ex-neurons is a main feature in Parkinson's and Alzheimer's disease, respectively. Two general approaches are pressing ChAT are of glial origin. This is indicated by the morphology of the transfected cells, which are of presently investigated for treating neurodegenerative disorders. First, application of recombinant purified neu-round-oval shape, being more close to the morphology of microglia and/or astroglia. In addition, all our in vitro roprotective molecules, like the growth factor NGF (5, 15, 34, 35, 40) , should protect neurons against cell death. experiments clearly point to an enhanced gene transfer efficiency in astroglial cells compared with neurons.
However, these molecules need to be delivered before the majority of the neurons degenerate. Second, trans-Thus, we favor the view that lipid-mediated gene transfer in vivo is mainly a "gliotropic" gene transfer system, plantation of embryonic neurons or of genetically modified cells (secreting growth factors or neurotransmitters) secreting the molecule of interest (e.g., acetylcholine or growth factors) and finally acting at the level of para-is an important alternative to repair or replace lost neuronal systems. Gene therapy has been an interesting al-crine transmission. Questions regarding the cell type transfected, the exact transfection efficiency in vivo, and ternative for the protection as well as replacement strategy. While several authors reported successful viral whether or not acetylcholine is synthesized and released by transfected cells remain to be investigated. gene therapy in the brain (3,28), the use of lipids for 
